{"id":5677,"date":"2022-11-04T16:54:09","date_gmt":"2022-11-04T08:54:09","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=5677"},"modified":"2022-12-27T11:03:14","modified_gmt":"2022-12-27T03:03:14","slug":"the-board-of-directors-approved-q3-2022-consolidated-financial-statements","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-approved-q3-2022-consolidated-financial-statements\/","title":{"rendered":"The Board of Directors approved Q3 2022 consolidated financial statements."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a01<\/td>\nDate of announcement<\/td>\n\u00a02022\/11\/04<\/td>\nTime of announcement<\/td>\n16:54:03<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The Board of Directors approved Q3 2022\r\nconsolidated financial statements.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2022\/11\/04<\/td>\nTo which item it meets<\/td>\nparagraph 31<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of submission to the board of directors or \r\n  approval by the board of directors:2022\/11\/04\r\n2.Date of approval by the audit committee:2022\/11\/04\r\n3.Start and end dates of financial reports or annual self\r\n  -assessed financial information of the reporting period\r\n  (XXXX\/XX\/XX~XXXX\/XX\/XX):2022\/01\/01~2022\/09\/30\r\n4.Operating revenue accumulated from 1\/1 to end of the \r\n  period (thousand NTD):5,223,756\r\n5.Gross profit (loss) from operations accumulated from 1\/1\r\n  to end of the period (thousand NTD):1,105,508\r\n6.Net operating income (loss) accumulated from 1\/1 to end \r\n  of the period (thousand NTD):445,100\r\n7.Profit (loss) before tax accumulated from 1\/1 to end of\r\n  the period (thousand NTD):737,862\r\n8.Profit (loss) accumulated from 1\/1 to end of the period\r\n  (thousand NTD):599,069\r\n9.Profit (loss) during the period attributable to owners \r\n  of parent accumulated from 1\/1 to end of the period \r\n  (thousand NTD):509,753\r\n10.Basic earnings (loss) per share accumulated from 1\/1\r\n   to end of the period (NTD):3.44\r\n11.Total assets end of the period (thousand NTD):\r\n   16,229,456\r\n12.Total liabilities end of the period (thousand NTD):\r\n   6,039,268\r\n13.Equity attributable to owners of parent end of the\r\n   period (thousand NTD):8,148,216\r\n14.Any other matters that need to be specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a01 Date of announcement \u00a02022\/11\/04 Time of announcement 16:54:03 Subject The Board of Directors approved Q3 2022 consolidated financial statements. Date of events 2022\/11\/04 To which item it meets paragraph 31 Statement 1.Date of submission to the board of directors or approval by the board of directors:2022\/11\/04 2.Date of approval by the audit …<\/p>\n
  The Board of Directors approved Q3 2022 consolidated financial statements.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-5677","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/5677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=5677"}],"version-history":[{"count":7,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/5677\/revisions"}],"predecessor-version":[{"id":5688,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/5677\/revisions\/5688"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=5677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=5677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=5677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}